Fertility warning
This medicine may affect fertility.
Leaflet VINCRISTINA TEVA 1mg / ml solution for injection
- Product code:
- W71016001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- injectable
- Substance:
- vincristine (antineoplastic agent)
- ATC
- L01CA02 — Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Vinca alkaloids and analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Neuropathy / neurotoxicity
This medicine may affect the nerves or nervous system.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Vincristine is a chemotherapy medication used for the treatment of various types of cancer, including acute lymphoblastic leukemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma, and Ewing's sarcoma. It belongs to the vinca alkaloid class and works by inhibiting microtubule formation, leading to the arrest of cell division and tumor cell death.
Vincristine is administered intravenously, usually once a week, and the dosage is adjusted based on body weight and patient response. Treatment is conducted under the supervision of an oncologist, and patients are monitored for signs of toxicity.
Common side effects include peripheral neuropathy, constipation, hair loss, nausea, and fatigue. In rare cases, severe adverse reactions such as liver function impairment or bone marrow depression may occur.
Vincristine is an essential component of many chemotherapy regimens, helping to reduce tumor size and improve survival rates in cancer patients.
Vincristine is administered intravenously, usually once a week, and the dosage is adjusted based on body weight and patient response. Treatment is conducted under the supervision of an oncologist, and patients are monitored for signs of toxicity.
Common side effects include peripheral neuropathy, constipation, hair loss, nausea, and fatigue. In rare cases, severe adverse reactions such as liver function impairment or bone marrow depression may occur.
Vincristine is an essential component of many chemotherapy regimens, helping to reduce tumor size and improve survival rates in cancer patients.
General data about VINCRISTINA TEVA 1mg / ml
- Substance:
- vincristine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W71016001
- Concentration:
- 1mg / ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 50.85 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for vincristine
Concentrations available for vincristine
- 1mg
- 1mg/ml